Mumbai-based pharmaceutical company Themis Medicare’s anti-viral drug Viralex has received Drugs Controller General of India’s (DCGI) approval, the company informed the stock exchange on Monday.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/42NXHh1
via IFTTT
0 comments:
Post a Comment